Construction and validation of an anti-inflammatory dietary regimen for gestational diabetes mellitus patients based on the Dietary Inflammatory Index

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300076605

Enrollment

Unknown

Registered

2023-10-12

Start date

2023-11-01

Completion date

Unknown

Last updated

2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational Diabetes Mellitus

Interventions

intervention group:Anti-inflammatory dietary intervention for gestational diabetes mellitus based on the construction of a dietary inflammation index

control group:Medical Nutritional Dietary Intervention for Gestational Diabetes Mellitus

Eligibility

Sex/Gender

Female

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Pregnant women who meet the diagnostic criteria for GDM by performing 75g OGTT at 24-28 weeks of pregnancy in the "Guidelines for Diagnosis and Treatment of Hyperglycemia in Pregnancy (2022)" in the obstetrics department of the regular obstetric checkups, and whose glucose thresholds at fasting, 1h and 2h after oral glucose intake are 5.1, 10.0, and 8.5 mmol/L, respectively, and whose glucose value reaches or exceeds the above criteria at any one of these points in time; 2. Aged >= 18 years old; 3. Those who have good verbal communication and comprehension skills, and have no conscious impairment; 4. Can have regular and regular obstetric examination; 5. Informed consent and voluntary participation in this study.

Exclusion criteria

Exclusion criteria: 1. With heart, liver and kidney diseases, gastrointestinal and nutritional diseases, thyroid diseases, etc.; 2. Accompanied by acute and chronic infectious diseases such as urinary system infectious diseases, digestive system infectious diseases, respiratory system infectious diseases; 3. Pre-pregnancy diabetes mellitus combined with pregnancy, pre-diabetes; 4. Those who are completely unable to eat by mouth (those who receive total enteral nutrition); 5. Those who have severe pregnancy reactions and are unable to eat regularly; 6. Those with twin or multiple pregnancies; 7. Combined cognitive dysfunction, mental disorder or unwillingness to co-operate.

Design outcomes

Primary

Measure	Time frame
inflammation marker;	—

Secondary

Measure	Time frame
Fasting blood glucose and 2h postprandial blood glucose values;glycated haemoglobi;immunity factor;sleep quality;quality of life;apprehensive;depression;Pregnancy outcomes;	—

Countries

China

Contacts

Public ContactZhao Mei

School of Nursing, Anhui Medical University

zhaomei@ahmu.edu.cn+86 139 6668 1076

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026